| Dr Hannah Pearce Hornsby, MD | |
|
2501 Capehart Rd, Offutt Afb, NE 68113-1043 | |
| (227) 340-2232 | |
| Not Available |
| Full Name | Dr Hannah Pearce Hornsby |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 2501 Capehart Rd, Offutt Afb, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609433267 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 8466 (Nebraska) | Primary |
| Entity Name | Unmc Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417912114 PECOS PAC ID: 6002728391 Enrollment ID: O20031104000664 |
News Archive
Oncology researchers studying gene mutations in the childhood cancer neuroblastoma are refining their diagnostic tools to predict which patients are more likely to respond to drugs called ALK inhibitors that target such mutations. Removing some of the guesswork in diagnosis and treatment, the researchers say, may lead to more successful outcomes for children with this often-deadly cancer.
Tengion, Inc., a leader in regenerative medicine, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application No. 12/617,721, titled "Isolated Renal Cells and Uses Thereof."
Misonix, Inc., a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, has entered into a new, three year, exclusive distribution agreement with Instrumentacion, S.A. based in Bogota, Colombia.
In a medical breakthrough two blind men have regained partial sight for the first time in more than 20 years after receiving a "bionic eye". Scientists said the first clinical trials of the microchip eye implant, which measures just 3mm across and is fitted behind the eyeball, have proved successful and "exceeded expectations".
Telesta Therapeutics Inc. announced today that it has submitted electronically, through its U.S. agent, a Biologics License Application (BLA) to the United States Food and Drug Administration for MCNA. MCNA is Telesta's novel biologic immunotherapeutic for the treatment of high-risk non-muscle invasive bladder cancer patients who have failed first-line BCG therapy.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hannah Pearce Hornsby, MD 2501 Capehart Rd, Offutt Afb, NE 68113-1043 Ph: () - | Dr Hannah Pearce Hornsby, MD 2501 Capehart Rd, Offutt Afb, NE 68113-1043 Ph: (227) 340-2232 |
News Archive
Oncology researchers studying gene mutations in the childhood cancer neuroblastoma are refining their diagnostic tools to predict which patients are more likely to respond to drugs called ALK inhibitors that target such mutations. Removing some of the guesswork in diagnosis and treatment, the researchers say, may lead to more successful outcomes for children with this often-deadly cancer.
Tengion, Inc., a leader in regenerative medicine, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application No. 12/617,721, titled "Isolated Renal Cells and Uses Thereof."
Misonix, Inc., a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, has entered into a new, three year, exclusive distribution agreement with Instrumentacion, S.A. based in Bogota, Colombia.
In a medical breakthrough two blind men have regained partial sight for the first time in more than 20 years after receiving a "bionic eye". Scientists said the first clinical trials of the microchip eye implant, which measures just 3mm across and is fitted behind the eyeball, have proved successful and "exceeded expectations".
Telesta Therapeutics Inc. announced today that it has submitted electronically, through its U.S. agent, a Biologics License Application (BLA) to the United States Food and Drug Administration for MCNA. MCNA is Telesta's novel biologic immunotherapeutic for the treatment of high-risk non-muscle invasive bladder cancer patients who have failed first-line BCG therapy.
› Verified 7 days ago
Dr. Baylee Austin Delozier, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-232-2273 | |
Dr. Scott L Wilson, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-294-6033 | |
Jill London, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-294-7346 | |
Alexander Edwards, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-232-2273 | |
Dr. Abigail Hawkins, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-232-2273 | |
Dr. Kristin Vogt, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-294-7346 | |
Boone Robinson Parkinson, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 401-294-2056 |